Inebilizumab-cdon was previously approved by the FDA for neuromyelitis optica spectrum disorder (NMOSD) in adults who are ...

At the recent ATTD 2025 meeting, participants discussed recent progress and remaining challenges in developing a fully closed ...

Survey shows that depression and anxiety are reported by more than half of patients newly diagnosed with lymphoma or myeloma.

Medications that help patients sleep linked to more falls, fractures, and other problems after joint procedures, a study ...

Low levels of soluble neuropilin-1 are associated with depression in patients with newly diagnosed type 2 diabetes, ...

When it comes to the use of testosterone for women’s health, Australia is among the world leaders. For this interview, Rachel ...

Hematologist-oncologist Mateo Mejia Saldarriaga, MD, combines clinical care with research aimed at helping patients with ...

Showing patients props and other visual aids improves recall of information, motivates patients, said doctors who have ...

Because the trial ended up being underpowered, it did not show a benefit of intensive medical treatment, but there was a high ...

A generative AI–powered therapy chatbot is linked to significant reductions in symptoms of depression, anxiety, and eating ...

Treatment with esketamine combined with an SNRI is linked to fewer adverse outcomes than treatment with an SSRI alone.

Secukinumab treatment reduces bone erosion volume and enhances partial healing of erosions in patients with psoriatic ...